Guoyu Tao
YOU?
Author Swipe
View article: A commentary on “Evaluating the association between time to skin grafting for truncal burn patients and complications: a comparative cohort study using the national trauma data bank”
A commentary on “Evaluating the association between time to skin grafting for truncal burn patients and complications: a comparative cohort study using the national trauma data bank” Open
View article: High Volume and High Positivity of Chlamydia and Gonorrhea Tests by Anatomic Site From a Large National Laboratory in the United States, 2019 to 2023
High Volume and High Positivity of Chlamydia and Gonorrhea Tests by Anatomic Site From a Large National Laboratory in the United States, 2019 to 2023 Open
Background Chlamydia and gonorrhea are among the most commonly reported sexually transmitted infections in the United States. Testing for chlamydia and gonorrhea infection can be conducted by anatomic site (site-specific). Monitoring testi…
View article: Treatment of Chlamydia and Gonorrhea in Primary Care and Its Patient-Level Variation: An American Family Cohort Study
Treatment of Chlamydia and Gonorrhea in Primary Care and Its Patient-Level Variation: An American Family Cohort Study Open
Guideline adherence remains suboptimal for chlamydia and gonorrhea treatment across primary care practices. Efforts are needed to develop interventions to improve quality of care for these sexually transmitted infections.
View article: Utilization of Treatment for Chlamydia and Gonorrhea in the Primary Care Setting Using the American Family Cohort
Utilization of Treatment for Chlamydia and Gonorrhea in the Primary Care Setting Using the American Family Cohort Open
CONTEXT: Chlamydia and gonorrhea are the two most common sexually transmitted infections (STI) in the United States. Since untreated cases can have severe health consequences, non-adherence to the Centers for Disease Control and Prevention…
View article: Sexually Transmitted Infection/Human Immunodeficiency Virus (STI/HIV) Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019–2022
Sexually Transmitted Infection/Human Immunodeficiency Virus (STI/HIV) Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019–2022 Open
Background Routine sexually transmitted infection and human immunodeficiency virus (STI/HIV) testing and HIV pre-exposure prophylaxis (PrEP) use are recommended for men who have sex with men (MSM) at increased risk of HIV. Methods Using He…
View article: Treatment Rates for Chlamydia trachomatis and Neisseria gonorrhoeae in a Metropolitan Area: Observational Cohort Analysis
Treatment Rates for Chlamydia trachomatis and Neisseria gonorrhoeae in a Metropolitan Area: Observational Cohort Analysis Open
Background Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) are the 2 most common sexually transmitted infections (STIs) in the United States. The Centers for Disease Control and Prevention regularly publishes and updates STI Trea…
View article: National Chlamydia Screening Rate in Young Sexually Active Women Using HEDIS Measures in the United States, 2011 to 2020
National Chlamydia Screening Rate in Young Sexually Active Women Using HEDIS Measures in the United States, 2011 to 2020 Open
Background National guidelines recommend sexually active women younger than 25 years be screened annually for chlamydia. Our objective was to estimate the chlamydia screening rate of sexually active women aged 16 to 24 years from 2011 to 2…
View article: Longitudinal Analysis of Electronic Health Information to Identify Possible COVID-19 Sequelae
Longitudinal Analysis of Electronic Health Information to Identify Possible COVID-19 Sequelae Open
Ongoing symptoms might follow acute COVID-19. Using electronic health information, we compared pre‒ and post‒COVID-19 diagnostic codes to identify symptoms that had higher encounter incidence in the post‒COVID-19 period as sequelae. This m…
View article: Findings From a Scoping Review: Presumptive Treatment for Chlamydia trachomatis and Neisseria gonorrhoeae in the United States, 2006–2021
Findings From a Scoping Review: Presumptive Treatment for Chlamydia trachomatis and Neisseria gonorrhoeae in the United States, 2006–2021 Open
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) are the 2 most common reported sexually transmitted infections in the United States. Current recommendations are to presumptively treat CT and/or GC in persons with symptoms or know…
View article: Impact of the Early COVID-19 Pandemic on the Number of HIV Preexposure Prophylaxis Uses and the Proportion of Preexposure Prophylaxis Users Receiving Sexually Transmitted Infection Testing Services
Impact of the Early COVID-19 Pandemic on the Number of HIV Preexposure Prophylaxis Uses and the Proportion of Preexposure Prophylaxis Users Receiving Sexually Transmitted Infection Testing Services Open
Background With the potential impact of the COVID-19 pandemic on HIV preexposure prophylaxis (PrEP) care management, we assessed the number of PrEP users and sexually transmitted infection (STI) testing–eligible PrEP users, STI testing rat…
View article: Access to Healthcare and the Utilization of Sexually Transmitted Infections Among Homeless Medicaid Patients 15 to 44 Years of Age
Access to Healthcare and the Utilization of Sexually Transmitted Infections Among Homeless Medicaid Patients 15 to 44 Years of Age Open
View article: Chlamydia trachomatis and Neisseria gonorrhoeae in Pregnancy: Trends in United States, 2010 to 2018.
Chlamydia trachomatis and Neisseria gonorrhoeae in Pregnancy: Trends in United States, 2010 to 2018. Open
Testing and adjusted positivity for both CT and NG among pregnant persons increased from 2010 to 2018. Higher testing rates were observed in Black non-Hispanic and Hispanic persons (even in persons younger than 25 years), suggesting some t…
View article: Syphilis testing adherence among women with livebirth deliveries: Indianapolis 2014-2016
Syphilis testing adherence among women with livebirth deliveries: Indianapolis 2014-2016 Open
View article: STI/HIV Testing and Prevalence of Gonorrhea and Chlamydia Among Persons with Their Specified-Type Sex Partner
STI/HIV Testing and Prevalence of Gonorrhea and Chlamydia Among Persons with Their Specified-Type Sex Partner Open
View article: A New Call to Action to Combat an Old Nemesis: Addressing Rising Congenital Syphilis Rates in the United States
A New Call to Action to Combat an Old Nemesis: Addressing Rising Congenital Syphilis Rates in the United States Open
Congenital syphilis (CS) is on the rise in the United States and is a growing public health concern. CS is an infection with Treponema pallidum in an infant or fetus, acquired via transplacental transmission when a pregnant woman ha…
View article: Chlamydia trachomatis and Neisseria gonorrhoeae in Pregnancy: Trends in United States, 2010 to 2018
Chlamydia trachomatis and Neisseria gonorrhoeae in Pregnancy: Trends in United States, 2010 to 2018 Open
Background Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) case surveillance relies on reported positive laboratory results. Changes in reported cases may represent changes in testing practice or infection prevalence. This study …
View article: Late Conditions Diagnosed 1–4 Months Following an Initial Coronavirus Disease 2019 (COVID-19) Encounter: A Matched-Cohort Study Using Inpatient and Outpatient Administrative Data—United States, 1 March–30 June 2020
Late Conditions Diagnosed 1–4 Months Following an Initial Coronavirus Disease 2019 (COVID-19) Encounter: A Matched-Cohort Study Using Inpatient and Outpatient Administrative Data—United States, 1 March–30 June 2020 Open
Background Late sequelae of COVID-19 have been reported; however, few studies have investigated the time course or incidence of late new COVID-19–related health conditions (post-COVID conditions) after COVID-19 diagnosis. Studies distingui…
View article: The Burden of and Trends in Pelvic Inflammatory Disease in the United States, 2006–2016
The Burden of and Trends in Pelvic Inflammatory Disease in the United States, 2006–2016 Open
Background Pelvic inflammatory disease (PID) is an infection of the upper genital tract that has important reproductive consequences to women. We describe the burden of and trends in PID among reproductive-aged women in the United States d…
View article: Chlamydia and Gonorrhea Screening Among Women Aged 15–24 Years Undergoing a Long-Acting Reversible Contraceptive Insertion
Chlamydia and Gonorrhea Screening Among Women Aged 15–24 Years Undergoing a Long-Acting Reversible Contraceptive Insertion Open
View article: Gonorrhea testing, morbidity, and reporting using an integrated sexually transmitted disease registry in Indiana: 2004–2016
Gonorrhea testing, morbidity, and reporting using an integrated sexually transmitted disease registry in Indiana: 2004–2016 Open
Surveillance of gonorrhea (GC), the second most common notifiable disease in the United States, depends on case reports. Population-level data that contain the number of individuals tested in addition to morbidity are lacking. We performed…
View article: Chlamydia Screening Among Women Aged 15 to 44 Years Who Reported Anal Sex During the Past 12 Months in the United States, 2013 to 2017
Chlamydia Screening Among Women Aged 15 to 44 Years Who Reported Anal Sex During the Past 12 Months in the United States, 2013 to 2017 Open
Using the 2013–2017 National Survey of Family Growth, 37.6% of women with ≥1 anal sex partner in the last 12 months reported chlamydia testing at unspecified anatomic sites in the past 12 months. Women whose medical provider asked about ty…
View article: Validation of International Classification of Diseases, Tenth Revision, Clinical Modification Codes for Identifying Cases of Chlamydia and Gonorrhea
Validation of International Classification of Diseases, Tenth Revision, Clinical Modification Codes for Identifying Cases of Chlamydia and Gonorrhea Open
Background While researchers seek to use administrative health data to examine outcomes for individuals with sexually transmitted infections (STIs), the International Classification of Diseases, Tenth Revision, Clinical Modification ( ICD-…
View article: Provider Adherence to Syphilis Testing Guidelines Among Stillbirth Cases
Provider Adherence to Syphilis Testing Guidelines Among Stillbirth Cases Open
Background The Centers for Disease Control and Prevention (CDC) recommends that all women with a stillbirth have a syphilis test after delivery. Our study seeks to evaluate adherence to CDC guidelines for syphilis screening among women wit…
View article: Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States, 2012–2017
Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States, 2012–2017 Open
Background Daily oral pre-exposure prophylaxis (PrEP) is highly effective in preventing human immunodeficiency virus (HIV) infection if used adherently throughout periods of HIV risk. We estimated PrEP persistence among cohorts of persons …
View article: O08.3 Rates of chlamydia and gonorrhea testing and positivity before and after initiation of PrEP among MSM in US private settings
O08.3 Rates of chlamydia and gonorrhea testing and positivity before and after initiation of PrEP among MSM in US private settings Open
Background The Centers for Disease Control and Prevention (CDC) recommends initial and follow-up STD and HIV testing when taking HIV pre-exposure prophylaxis (PrEP). We assessed frequencies of STD and HIV testing and rates of STDs among me…
View article: P068 STD screening and diagnosis among 15–24 year old diagnosed with prescription opioid related disorder
P068 STD screening and diagnosis among 15–24 year old diagnosed with prescription opioid related disorder Open
Background Many injection drug users have elevated STD/HIV risks, such as sexual-trade for drugs, risky condom-less sex, or multiple sex partners. STD diagnosis and screening among opioid users has not been examined. Methods Using 2016 Mar…
View article: P491 Determining recommended chlamydia and gonorrhea treatment using linked medical claims, prescription and laboratory data
P491 Determining recommended chlamydia and gonorrhea treatment using linked medical claims, prescription and laboratory data Open
Background The Centers for Disease Control and Prevention (CDC) recommends specific regimens for treatment of chlamydia and gonorrhea. Dual therapy is recommended for gonococcal infection to mitigate antimicrobial resistant gonorrhea (250 …
View article: P026 Frequency of STD testing services among commercially-insured patients with high risk sexual behaviors
P026 Frequency of STD testing services among commercially-insured patients with high risk sexual behaviors Open
Background High-risk sexual behavior (HRSB) is associated with an increased burden of sexually transmitted diseases (STDs); therefore, CDC recommends those at high risk are screened more frequently than persons without HRSB. Because provid…
View article: Syphilis Testing among Men Who Have Had Rectal Gonorrhea and Chlamydia Tests, United States
Syphilis Testing among Men Who Have Had Rectal Gonorrhea and Chlamydia Tests, United States Open
View article: Where Do People Go for Gonorrhea and Chlamydia Tests: A Cross-Sectional View of the Central Indiana Population, 2003–2014
Where Do People Go for Gonorrhea and Chlamydia Tests: A Cross-Sectional View of the Central Indiana Population, 2003–2014 Open
Background Despite major efforts to control their spread, reported sexually transmitted infections (STI) are increasing. Using data from a mid-sized Midwest metropolitan area, we examined the settings in which individuals are tested for go…